Full-Year Revenue and EPS Growth
Consolidated full-year adjusted revenues of $275 billion, an 11% increase year-over-year, and full-year adjusted earnings per share of $29.84, a 9% increase versus prior year.
Strong EverNorth Performance
EverNorth Q4 revenues of $63.1 billion with pretax adjusted earnings of $2.2 billion; specialty and care services revenue of $26.7 billion, up 14% year-over-year, contributing $1.0 billion in adjusted earnings; pharmacy benefit services revenue of $36.3 billion and $1.2 billion in adjusted earnings.
Specialty Script and Platform Growth
Specialty pharmacy scripts grew ~13% year-over-year in 2025; specialty and care platforms now represent ~35% of company income (up from ~25% three years ago), with long-term expected AOI growth of 8%–12%.
PBM Transformation and Regulatory Resolution
Announced and advancing a rebate-free, fee-based pharmacy benefit model aligned with recent PBM reform and the FTC settlement; Cigna highlighted that its new model positions it to deliver the settlement commitments and expects the Cigna Healthcare fully insured book to adopt the model on 1/1/2027 and at least 50% of EverNorth to adopt by year-end 2028.
FTC Settlement Benefits for Customers
Global FTC settlement resolves pharmacy benefits matters and is expected to deliver approximately $7 billion in out-of-pocket cost relief over the next ten years for the ~100 million customers and patients served by the company.
Customer Experience and Retention
Customer net promoter scores improved year-over-year across largest businesses; prior authorization volume reduced by 15%; pharmacy benefit services retention rate over 97% for 2026 renewals; select segment customers grew ~7%.
Capital Deployment and Balance Sheet Progress
Returned over $5 billion to shareholders in 2025 (repurchased 11.9 million shares for ~$3.6 billion and $1.6 billion in dividends); generated $9.6 billion of operating cash flow in 2025; improved debt-to-capitalization to 43% (190 bps improvement in Q4).
2026 Financial Outlook
Guidance for 2026: consolidated adjusted revenues of ~ $280 billion and adjusted EPS of at least $30.25 (implying modest year-over-year EPS growth); segment guidance includes EverNorth adjusted earnings of at least $6.9 billion and Cigna Healthcare adjusted earnings of at least $4.5 billion.